Lattice Biologics Ltd. is a biotech company developing life-changing regenerative medicine solutions and cancer diagnostic services and is listed as (TSX-V: LBL) (OTCQB: LBLTF). Watch for updates to view our stock charts and other information about our stock.
Reports found below have been sent to Lattice Biologics Ltd., by courtesy of the banks and investment companies, for inclusion in the investor relations section of the website. Lattice Biologics Ltd. is not responsible for the content of these reports and your attention is drawn to the disclaimer below.
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 30, 2017
Please Note: There has been a change to location of the Annual General and Special Meeting read details.
Management Information Circular
Proxy (Common Shares)
Proxy (Restricted Shares)
Voting Instruction Form
SEDAR FILING STATEMENT
12/23/15: Change of Business Involving Acquisition by Blackstone Ventures Inc. of all of the Issued and Outstanding Share Capital of Lattice Biologics Inc. Click Here.
Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.
Find out which analysts and institutions provide coverage of Lattice Biologics Ltd.
View Analyst Coverage
These reports have not been prepared by Lattice Biologics Ltd., (“Lattice Biologics” or the “Company”) and Lattice Biologics does NOT adopt or endorse the contents hereof, which constitute the opinion solely of the report’s authors. Lattice Biologics disclaims any representation, either express or implied, that the information in these reports are accurate or that the statements in these reports reflects the Company’s views. Further, the Company disclaims any obligation to furnish any other published reports or updates, whether or not by the same authors and whether or not the contents thereof are consistent with the information and views expressed in these reports.